Which of the following was added in 1997 to the Orphan Drug Act of 1983?
A) A tax credit of 50% of the cost of conducting human clinical trials
B) Exemption from the usual drug application or user fees charged by the FDA for granted companies developing orphan products
C) Federal research grants for clinical testing of new therapies to treat and/or diagnose rare diseases
D) 7-year market exclusivity to sponsors of approved orphan products
B
You might also like to view...
Letterhead stationery, which contains the name and address of the sender, comes in all three of the commonly used sizes EXCEPT
a. 19 x 37. b. standard. c. monarch or executive. d. baronial.
A description of a patient's condition that assists a clinician in further evaluation and treatment is known as which of the following?
A) Critical thinking B) Diagnosis C) Clinical decision D) Red flag